Breast cancer medicines known as aromatase inhibitors may diminish the benefit of weight loss therapies, according to a new study presented at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.
According to a new study presented at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill., breast cancer treatments known as aromatase inhibitors may reduce the effect of weight reduction therapies.
The UC Davis Comprehensive Cancer Center conducted a study to investigate the usage of the South Asian spice Turmeric to reduce joint pain and discomfort during breast cancer treatments.